Cargando…
Predictive value and accuracy of [(18)F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
PURPOSE: Immune checkpoint inhibitors (ICIs) are widely used in metastatic melanoma and dramatically alter the treatment of these patients. Given the high cost and potential toxicity, a reliable method for evaluating treatment response is needed. In this study, we assessed tumor response in patients...
Autores principales: | Ayati, Narjess, Jamshidi-Araghi, Zahra, Hoellwerth, Magdalena, Schweighofer-Zwink, Gregor, Hitzl, Wolfgang, Koelblinger, Peter, Pirich, Christian, Beheshti, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317870/ https://www.ncbi.nlm.nih.gov/pubmed/37140669 http://dx.doi.org/10.1007/s00259-023-06247-8 |
Ejemplares similares
-
Impact of [(18)F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
por: Ranjbar, Shaghayegh, et al.
Publicado: (2023) -
Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2021) -
Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
por: Rendl, Gundula, et al.
Publicado: (2022) -
Feasibility of equivalent performance of 3D TOF [(18)F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters
por: Pilz, Julia, et al.
Publicado: (2021) -
Incremental Impact of [(68) Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI
por: Szigeti, Florian, et al.
Publicado: (2021)